Back
Arbutus Biopharma Vs. RH Industry Stock Comparison
Sell
29
ABUS
Arbutus Biopharma
Last Price:
$3.30
Seasonality Move:
1.39%
Sell
35
RH
RH
Last Price:
$225.25
Seasonality Move:
17.71%
Sell
29
Arbutus Biopharma (ABUS)
is a Sell
Is Arbutus Biopharma a Buy, Sell or Hold?
-
The current Arbutus Biopharma [ABUS] share price is $3.30. The Score for ABUS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
ABUS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
RH (RH)
is a Sell
Is RH a Buy, Sell or Hold?
-
RH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABUS Stock Price Chart
What is Arbutus Biopharma's stock price today?
-
The Arbutus Biopharma share price today is $3.30Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.
ABUS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 48.66 | Sell |
Chaikin Money Flow: | -530525 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.27 - 3.47) | Sell |
Bollinger Bands (100): | (3.23 - 3.77) | Sell |
RH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -44.02 | Sell |
Relative Strength Index (14 RSI): | 22.36 | Sell |
Chaikin Money Flow: | 703318 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (271.41 - 394.57) | Sell |
Bollinger Bands (100): | (316.4 - 417.74) | Sell |
ABUS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.3 | Buy |
20-day SMA: | 3.35 | Sell |
50-day SMA: | 3.33 | Sell |
200-day SMA: | 3.59 | Sell |
8-day EMA: | 3.3 | Buy |
20-day EMA: | 3.33 | Sell |
50-day EMA: | 3.37 | Sell |
200-day EMA: | 3.39 | Sell |
RH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 254.79 | Sell |
20-day SMA: | 315.55 | Sell |
50-day SMA: | 375.12 | Sell |
200-day SMA: | 320.75 | Sell |
8-day EMA: | 254 | Sell |
20-day EMA: | 301.75 | Sell |
50-day EMA: | 346.39 | Sell |
200-day EMA: | 334.48 | Sell |
Arbutus Biopharma Earnings Growth & ABUS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.08 per share.
RH Earnings Growth & RH Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.69 per share, a decrease next quarter of $0.78 per share, a decrease this year of $2.07 per share, and an increase next year of $7.32 per share.
Arbutus Biopharma Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
RH Technical Analysis
Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |